Rosen MI, Bridge TP, O'Malley SS, Pearsall HR, Martini B, O'Connor PG, Brett-Smith H, Thomas HM, van Dyck CH, Woods SW, Kosten TR: Peptide T treatment of cognitive impairment in HIV-positive intravenous drug users. The American Journal on Addictions, 1992; 1(3): 1-7.
Jenkins SW, Warfield NA, Blaine JD, Cornish J, Ling W, Rosen MI, Urschel H, Wesson D, Ziedonis D: A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency. Psychopharmacology Bulletin, 1992; 28(1): 21-26.
Rosen MI, Pearsall HR, McDougle CJ, Price LH, Woods SW, Kosten TR: Effects of acute buprenorphine on responses to intranasal cocaine: a pilot study. American Journal of Drug and Alcohol Abuse, 1993; 19(4): 451-464.
Rosen MI, Pearsall HR, Price LH, McDougle CJ, Woods SW, Kosten TR: Carbamazepine vs. oxazepam for benzodiazepine detoxification in methadone-maintained patients. The American Journal on Addictions, 1993; 2(2): 165-168.
Rosen MI, Wallace EA, McMahon TJ, Pearsall HR, Woods SW, Price LH, Kosten TR: Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. Drug and Alcohol Dependence, 1994; 35: 141-149.
van Dyck CH, Rosen MI, Thomas HM, McMahon TJ, Wallace EA, O’Connor PG, Sullivan M, Krystal JH, Hoffer PB, Woods SW, Kosten TR: SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine. Psychiatry Research: -Neuroimaging 1994; 55: 181-191.
Oliveto AH, Rosen MI, Woods SW, Kosten TR: Discriminative stimulus, self-reported and cardiovascular effects of orally-administered cocaine in humans. The Journal of Pharmacology and Experimental Therapeutics, 1995; 272(1): 231-234.
Krystal JH, Woods SW, Kosten TR, Rosen MI, Seibyl JP, van Dyck CC, Price LH, Zubal IG, Hoffer PB, Charney DS: Opiate dependence and withdrawal; preliminary assessment using single photon emission computerized topography (SPECT). American Journal of Drug and Alcohol Abuse, 1995; 21(1): 47-63.
Hameedi FA, Rosen MI, McCance-Katz EF, McMahon TJ, Price LH, Jatlow PI, Woods SW, Kosten TR: Behavioral, physiological and pharmacological interaction of cocaine and disulfiram. Biological Psychiatry, 1995; 34: 560-563.
Rosen MI, McMahon TJ, Margolin A, Gill TS, Woods SW, Pearsall HR, Kreek MJ, Kosten TR: Reliability of sequential naloxone challenge tests. American Journal of Drug and Alcohol Abuse, 1995; 21(4): 453-467.
Kosten TA, DeCaprio JL, Rosen MI: The severity of naloxone-precipitated opiate withdrawal is attenuated by the glycine agents felbamate and d-cycloserine. Neuropsychopharmacology, 1995; 13(4): 323-333.
Rosen MI, McMahon TJ, Hameedi FA, Pearsall HR, Woods SW, Kreek MJ, Kosten TR: Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal. The Journal of Pharmacology and Experimental Therapeutics, 1996; 276(3): 1128-1135.
Kosten TR, Kosten TA, McDougle CJ, Hameedi FA, McCance EF, Rosen MI, Oliveto AH, Price LH: Gender differences in response to intranasal cocaine administration to humans. Biological Psychiatry, 1996; 39: 147-148.
Wallace EA, Wisniewski G, Zubal G, van Dyck CH, Pfau SE, Smith EO, Rosen MI, Sullivan MC, Woods SW, Kosten TR: Acute cocaine effects on absolute cerebral blood flow. Psychopharmacology, 1996; 128(1): 17-20.
van Dyck CH, McMahon TJ, Rosen MI, O'Malley SS, O'Connor PG, Lin CH, Pearsall HR, Woods SW, Kosten TR: Sustained-release methylphenidate for cognitive impairment in HIV-infected drug abusers: A pilot study. Journal of Neuropsychiatry and Clinical Neurosciences, 1997; 9: 29-36.
Kosten TR, Rosen MI, Bridge TP, O'Malley SS, Pearsall HR, McMahon TJ, O'Connor PG: Treatment of early AIDS dementia in intravenous drug users: High versus low dose peptide T. American Journal of Drug and Alcohol Abuse, 1997; 23(4): 543-553.
Oliveto AH, Rosen MI, Kosten TA, Hameedi F, Woods SW, Kosten TR: Naloxone discrimination in opioid-dependent subjects under a novel-response discrimination procedure. Journal of Experimental and Clinical Psychopharmacology, 1998; 6(2): 169-178.
Winther LC, Saleem R, McCance-Katz EF, Rosen MI, Hameedi FA, Pearsall HR, Jatlow PI, Kosten TR, Woods SW: Effect of lamotrigine on behavioral and cardiovascular responses to cocaine in human subjects. American Journal of Drug and Alcohol Abuse 2000; 26 (1): 47-59.
Rigsby MO, Rosen MI, Beauvais JE, Cramer JA, Rainey PM, O’Malley SS, Dieckhaus KD, Rounsaville BJ: Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. Journal of General Internal Medicine 2000; 15: 841-847.
Rosen MI, Rosenheck R, Shaner A, Eckman T, Gamache G, Krebs C: Substance abuse and the need for money management assistance among psychiatric inpatients. Drug and Alcohol Dependence 2002; 67 (3): 331-334.
Rosen MI, Bailey M, Dombrowski E, Ablondi K, Rosenheck RA: A comparison of satisfaction with clinician, family members/friends and attorneys as payees. Community Mental Health Journal 2005; 41 (3): 291-306.
Black, R.A., Rounsaville, B.J., Rosenheck, R.A., Conrad, K.C., Ball, S.A., Rosen M.I.: Measuring money mismanagement among dually diagnosed clients. Journal of Nervous and Mental Disorders 2008; 196: 576-579. NIHMSID 165779, PMCID 2804268.
Rosen MI, Carroll KM, Stefanovics EA, Rosenheck RA: A Randomized Controlled Trial of a Money-Management Based Intervention Targeting Substance Use. Psychiatric Services 2009; 60(4): 498-504. PMC2831204.
Le T, Chiarella J, Simen BB, Hanczaruk B, Egholm M, Landry ML, Dieckhaus K, Rosen MI, Kozal MJ: Low-Abundance HIV Drug-Resistant Viral Variants in Treatment-Experienced Persons Correlate with Historical Antiretroviral Use. PLoS (Public Library of Science) ONE 2009; 4(6):e6079. PMCID 2698118.
Contardo C, Beauvais JE, Dieckhaus KD, Rosen MI: Relationship of Prospective Memory to Neuropsychological Function and Antiretroviral Adherence. Archives of Clinical Neuropsychology 2009; 24(6):547-54. PMCID 2764502.
Black AC, Serowik KL, Ablondi K, Rosen MI: Timeline Historical Review of Income and Financial Transactions: A Reliable Assessment of Personal Finances. Journal of Nervous & Mental Disease 2013; 201: 56-59.